Trial Profile
Umirolimus- and sirolimus-eluting stents for coronary revascularisation in the Japanese population.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Feb 2013
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.